1 / 3

Thebaine Market Set to Expand Saliently at a Robust CAGR during the Forecast Period 2018-2026

Thebaine is an opioid alkaloid also called as codeine methyl enol ether. Although it is a minor constituent of opium i.e. thebaine is chemically similar to codeine and morphine, thebaine has stimulatory effects instead of depressant effects.

coherent
Download Presentation

Thebaine Market Set to Expand Saliently at a Robust CAGR during the Forecast Period 2018-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Thebaine Market Set to Expand Saliently at a Robust CAGR during the Forecast Period 2018- 2026 Thebaine Market, by Applications (Oxymorphone, Nalbuphine, Naltrexone, Naloxone, Oxycodone, Buprenorphine, and Others), by Distribution Channels (Hospitals/Clinics, Online Pharmacies, and Retail pharmacies), by Region (North America, Europe, Latin America, Asia Pacific, Middle East, and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2018 - 2026. Thebaine is an opioid alkaloid also called as codeine methyl enol ether. Although it is a minor constituent of opium i.e. thebaine is chemically similar to codeine and morphine, thebaine has stimulatory efects instead of depressant efects. Thebaine is white crystalline substance, which is slightly soluble in water. It is more lethal substance as compared to morphine therefore it said to be poisonous alkaloid. Download PDF Brochure of Market Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1908 Thebaine Market drivers:- Launch of new campaigns to promote drug abuse treatment is expected to be a major driver for growth of global thebaine market. For instance, in 2018, Trump administration i.e. White House Administration launched a multi-million dollar opioid awareness campaign for young adults. This campaign aims at curbing addition of opioid among young population. This campaign also spreads awareness by sharing true life stories of drug addicts to educate teens as well as young adults. According to a survey conducted by Substance Abuse and Mental health Services administration in 2018, opioid crisis kills an average of 116 Americans annually. Such government organized campaigns and high number of people dying due to opioid crisis are expected to encourage people to get rid of substance abuse addiction using diferent treatments available to live a healthy life. Browse more about the Deep Brain Stimulation Devices Market Study: https://www.coherentmarketinsights.com/insight/request-customization/1908

  2. Market Players API Labs Inc., Alcaliber S.A., Sanof S.A., Faran Shimi pharmaceutical Co., Mallinckrodt Pharmaceuticals, Noramco Inc,. and Tasmania Alkaloids Pvt. Ltd. Thebaine Market Taxonomy:- By Applications:- •Oxymorphone •Nalbuphine •Naltrexone •Naloxone •Oxycodone •Buprenorphine •Others By Distribution Channels:- •Hospitals/Clinics •Online Pharmacies •Retail pharmacies By Region:- •North America •Europe •Latin America •Asia Pacifc •Middle East •Africa About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

  3. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related